NCT03984890View on ClinicalTrials.gov

Vitamin D3 For CGD Patients With BCGosis/Itis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2023

Conditions
Vitamin D3Chronic-granulomatous DiseaseBCG
Interventions
DRUG

Vitamin D3

Vitamin D3 drops 800IU/d for 3 months

DRUG

Traditional treatment of CGD and TB

Anti-tuberculosis drugs, interferon-gamma

Trial Locations (2)

201102

Children's Hospital of Fudan University, Shanghai

Unknown

Children's Hospital of Fudan University, Shanghai

All Listed Sponsors
lead

Children's Hospital of Fudan University

OTHER

NCT03984890 - Vitamin D3 For CGD Patients With BCGosis/Itis | Biotech Hunter | Biotech Hunter